An infectious disease expert explains the results from Moderna’s latest vaccine trials

Biotech company Moderna, one of many organizations developing a vaccine for COVID-19, published results from an early-stage test of its experimental mRNA vaccine in the New England Journal of Medicine on July 14. Vanderbilt University Medical Center staff scientist and protein chemistry expert Sanjay Mishra explains what the results of the phase 1 trial mean.
Licence
Creative Commons Attribution licence (reuse allowed)